Buccal Misoprostol compared with synthetic osmotic cervical dilator before surgical abortion: A randomized controlled trial

Obstetrics and Gynecology

Volumn 122, Issue 1, 2013, Pages 57-63

  Bartz, Deborah ^a   Maurer, Rie ^b   Allen, Rebecca H ^b   Fortin, Jennifer ^b   Kuang, Bernice ^b   Goldberg, Alisa B ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; LACERATION; MAJOR CLINICAL STUDY; NORMAL HUMAN; OPERATION DURATION; OSMOTIC CERVICAL DILATOR; PARITY; PATIENT SATISFACTION; PREGNANCY OUTCOME; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SECOND TRIMESTER PREGNANCY; SURGICAL ABORTION; TREATMENT OUTCOME; UTERINE CERVIX LACERATION; UTERINE CERVIX RIPENING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LABOR STAGE, FIRST; MISOPROSTOL; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; TREATMENT OUTCOME;

EID: 84880573103     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182983889     Document Type: Article

References (21)

1. Schulz KF, Grimes DA, CatesWJr.Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182-5.
2. Meirik O, My Huong NT, Piaggio G, Bergel E, von Hertzen H; WHO Research Group on Postovulatory Methods of Fertility Regulation. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomized trial. Lancet 2012;379:1817-24.
3. Kapp N, Lohr PA, Ngo TD, Hayes JL. Cervical preparation for first trimester surgical abortion. The Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD007207. DOI: 10. 1002/14651858.CD007207.pub2
4. O'Connell K, Jones HE, Lichtenberg ES, Paul M. Secondtrimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 2008;78:492-9.
5. O'Connell K, Jones HE, Simon M, Saporta V, Paul M, Lichtenberg ES. First-trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 2009;79:385-92.
6. Eaton CJ, Cohn F, Bollinger CC. Laminaria tent as a cervical dilator prior to aspiration-type therapeutic abortions. Obstet Gynecol 1972;39:535-7.
7. Gold RB, Nash E. Troubling Trend: More States Hostile to Abortion Rights as Middle Ground Shrinks. Available at: http://www.guttmacher.org/pubs/gpr/15/1/ gpr150114.html. Accessed August 7, 2012.
8. Meckstroth KR, Darney PD. Prostaglandins for first-trimester termination. Best Pract Res Clin Obstet Gynaecol 2003;17:745-63.
9. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by four epithelial routes: drug absorption and uterine response. Obstet Gynecol 2006; 108:582-90.
10. Singh K, Fong YF, Prasad RN, Dong F. Evacuation interval after vaginal misoprostol for pre-Abortion cervical priming: a randomized trial. Obstet Gynecol 1999;94:431-4.
11. Allen RH, Goldberg AB. Society of Family Planning Clinical Guidelines: cervical dilation before first-trimester surgical abortion (,14 weeks gestation). Society of Family Planning, San Francisco, CA, 2007. Contraception 2007;76:139-56.
12. Goldberg AB, Drey EA, Whitaker AK, Kang MS, Meckstroth KR, Darney PD. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol 2005;106:234-41.
13. Patel A, Talmont E, Morfesis J, Pelta M, Gatter M, Momtaz MR, et al. Planned Parenthood Federation of America Buccal Misoprostol Waiver Group. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception 2006;73:420-30.
14. Maurer KA, Jacobson JC, Turok DK. Same-day cervical preparation with misoprostol prior D&E: a case series. Contraception 2013 Jan 2 [Epub ahead of print].
15. FEMA International, B.V. and JCEC Company, Inc. Dilapan-S hygroscopic cervical dilator: international instructions for use. Kendall Park (NJ): JCEC Company, Inc.; c2008. Available at: http://www.dilapan.com/departments/item. aspx?Item- Id535&DepartmentId52. Retrieved August 7, 2012.
16. Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv 2004;59:528-36.
17. Wilson LC, Meyn LA, Creinin MD. Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S. Contraception 2011;83:511-6.
18. Bokstrom H, Wiqvist N. Preoperative dilation of the cervix at legal abortion with a synthetic, fast-swelling hygroscopic tent. Acta Obstet Gynecol Scand 1989;68:313-8.
19. Darney PD, Dorward K. Cervical dilation before first-trimester elective abortion: a controlled comparison of meteneprost, laminaria, and hypan. Obstet Gynecol 1987;70:397-400.
20. Jones RK, Darroch JE, Henshaw SK. Patterns in the socioeconomic characteristics of women obtaining abortions in 2000- 2001. Perspect Sex Reprod Health 2002;34:226-35.
21. Sedgh G, Singh S, Shah IH, Ahman E, Henshaw SK, Bankole A. Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet 2012;379:625-32.